Skip to content

Xencor XNCR Change in Other Assets

Change in Other Assets at other companies

Amgen logo
AmgenAMGN
-$8M-104%
Janux Therapeutics logo
Janux TherapeuticsJANX
$1.34M+1,552%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.74M+124%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$1.5M-183%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$1.48M+60.0%
Absci Corporation logo
Absci CorporationABSI
$0+100%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's change in other assets?
Xencor (XNCR) reported change in other assets of $2.17M in Q1 2026.
How has Xencor's change in other assets changed year-over-year?
Xencor's change in other assets increased by 142.8% year-over-year, from -$5.06M to $2.17M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.